A bit of info in trials which I copied from an ann - just a refresher for whats going on behind the scenes for some that may have forgotten. Order of the dates below is Commencement Date, Completion Date and Results announced. Its possible some of these have been completed since the ann was an older one!
Solagrans trials program is larger and more complex than a number of Biotechnology and Pharmaceutical companies many times our size. The diagram below illustrates how we have progressed during the year: Some of the highlights have been:
�� A clinical effi cacy trial with Alzheimer’s patients from the Skvortsov-Stepanov Psychiatric Hospital in St Petersburg which demonstrated that four months treatment with Ropren could potentially eliminate many of the symptoms of Alzheimer’s disease, and at the same time enable the restoration of lost cognitive function, rather than just slow the rate of cognitive decline like other Alzheimer’s treatments,
�� A comprehensive anti-microbial and anti-fungal study undertaken and the I.I. Mechnikov State Medical Academy in St Petersburg which demonstrated the ability of Bioeffective A to deal with a range of different strains of bacteria and fungi – including Methicillin Resistant Staphylococcus strains (such as MRSE and MRSA which are responsible for a large proportion of hospital infections) and Candida Albicans (the fungus that causes Thrush),
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)